Cancer Focus Fund
Cancer Focus Fund

Cancer Focus Fund

DR22Ahrefs DR: 22/100. Below median. Measured by Ahrefs. Median 44.

2020Venture Capital2 portfolio

About

The Cancer Focus Fund is an oncology-focused investment fund which invests in compelling cancer therapies at or near the FDA Phase 1 or Phase 2 human clinical trial regimen. The fund offers business, management, IP, clinical, scientific and regulatory support through experienced and proven professionals. At the Cancer Focus Fund, we invest in promising therapies in late preclinical development through Phase I and Phase Ib/II clinical trials.

Key facts

At-a-glance profile data

Website
cancerfocusfund.com
Type
Venture Capital
Portfolio companies
2
Stages
Series B
Cheque size
$5M to $5M
Sector focus
Life Sciences
Immunotherapy
Immunology
Cancer
Cancer Immunotherapy

Recent investments

Recent funding rounds Cancer Focus Fund took part in
DateCompanyRoundAmount
28 Oct 2024Starget PharmaSeries B$5M
9 Mar 2022178854Series A$5M
Add first review

Frequently asked

What companies has Cancer Focus Fund invested in?

Cancer Focus Fund has invested in Starget Pharma, 178854, Nectin Therapeutics.